Caroline Loew, Ph.D.  is the President and CEO of Glympse Bio, an MIT spin out company trying to change the paradigm of in vivo diagnostic and prognostic monitoring for a wide range of disease indications. Prior to running Glympse Bio, Caroline held a number of high-level positions within some of the top global pharmaceutical companies including Merck and most recently Bristol Myers-Squibb. Her roles spanned a number of business units related to market access, commercialization, strategy, and planning. Dr. Loew earned a Ph.D. in organic chemistry from Imperial College London.

In this episode, Caroline shares her insights learned from a fruitful career in biotech and pharma. She highlights the idea of building the base of your career following your Ph.D.. Additionally, Caroline discusses the founding and development of Glympse Bio- and shares some of the key areas of development for the company and their technology over the next 5 years.

Hosted by Joe Varriale.